Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Monoferric Infusion for Elective Abdominal Surgery
NCT05258825Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2023
- Primary completion
- Jun 2025
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Brigham and Women's Hospital. Primary endpoint: Serum hemoglobin concentration. Started Apr 2023; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05258825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05258825.